Clinical Trial Update: Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating 18F-Al-NOTA-PRGD2 as a cancer imaging agent; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Lung Cancer
• Lymphoma
• Soft Tissue Sarcoma

Drugs mentioned

• 18F-Al-NOTA-PRGD2

Snippet

Sponsor: Wuxi No. 4 People's Hospital | Conditions: Tumors, Carcinoma, Bronchogenic | Phase 1 | Status: UNKNOWN